Cargando…
The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives
Sodium glucose cotransporter 2 inhibitors (SGLT2) have been increasingly pursued as a promising target for addressing residual cardiovascular risk. Prior trials demonstrated that SGLT2i not only promotes glucose-lowering, but also improves endothelial dysfunction, adiposity, fluid overload, and insu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562622/ https://www.ncbi.nlm.nih.gov/pubmed/37822556 http://dx.doi.org/10.3389/fcdhc.2023.1243530 |
_version_ | 1785118168359895040 |
---|---|
author | Barreto, Joaquim Campos-Staffico, Alessandra M. Nadruz, Wilson Quinaglia, Thiago Sposito, Andrei C. |
author_facet | Barreto, Joaquim Campos-Staffico, Alessandra M. Nadruz, Wilson Quinaglia, Thiago Sposito, Andrei C. |
author_sort | Barreto, Joaquim |
collection | PubMed |
description | Sodium glucose cotransporter 2 inhibitors (SGLT2) have been increasingly pursued as a promising target for addressing residual cardiovascular risk. Prior trials demonstrated that SGLT2i not only promotes glucose-lowering, but also improves endothelial dysfunction, adiposity, fluid overload, and insulin sensitivity thus contributing to hemodynamic changes implicated in its cardiorenal benefits. The mechanisms in the effect of SGLT2i on blood pressure and their potential role in preventing cardiovascular events are hereby revised. |
format | Online Article Text |
id | pubmed-10562622 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105626222023-10-11 The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives Barreto, Joaquim Campos-Staffico, Alessandra M. Nadruz, Wilson Quinaglia, Thiago Sposito, Andrei C. Front Clin Diabetes Healthc Clinical Diabetes and Healthcare Sodium glucose cotransporter 2 inhibitors (SGLT2) have been increasingly pursued as a promising target for addressing residual cardiovascular risk. Prior trials demonstrated that SGLT2i not only promotes glucose-lowering, but also improves endothelial dysfunction, adiposity, fluid overload, and insulin sensitivity thus contributing to hemodynamic changes implicated in its cardiorenal benefits. The mechanisms in the effect of SGLT2i on blood pressure and their potential role in preventing cardiovascular events are hereby revised. Frontiers Media S.A. 2023-09-26 /pmc/articles/PMC10562622/ /pubmed/37822556 http://dx.doi.org/10.3389/fcdhc.2023.1243530 Text en Copyright © 2023 Barreto, Campos-Staffico, Nadruz, Quinaglia and Sposito https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Clinical Diabetes and Healthcare Barreto, Joaquim Campos-Staffico, Alessandra M. Nadruz, Wilson Quinaglia, Thiago Sposito, Andrei C. The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives |
title | The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives |
title_full | The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives |
title_fullStr | The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives |
title_full_unstemmed | The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives |
title_short | The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives |
title_sort | role of sglt2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives |
topic | Clinical Diabetes and Healthcare |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562622/ https://www.ncbi.nlm.nih.gov/pubmed/37822556 http://dx.doi.org/10.3389/fcdhc.2023.1243530 |
work_keys_str_mv | AT barretojoaquim theroleofsglt2iinattenuatingresidualcardiovascularriskthroughbloodpressureloweringmechanisticinsightsandperspectives AT camposstafficoalessandram theroleofsglt2iinattenuatingresidualcardiovascularriskthroughbloodpressureloweringmechanisticinsightsandperspectives AT nadruzwilson theroleofsglt2iinattenuatingresidualcardiovascularriskthroughbloodpressureloweringmechanisticinsightsandperspectives AT quinagliathiago theroleofsglt2iinattenuatingresidualcardiovascularriskthroughbloodpressureloweringmechanisticinsightsandperspectives AT spositoandreic theroleofsglt2iinattenuatingresidualcardiovascularriskthroughbloodpressureloweringmechanisticinsightsandperspectives AT barretojoaquim roleofsglt2iinattenuatingresidualcardiovascularriskthroughbloodpressureloweringmechanisticinsightsandperspectives AT camposstafficoalessandram roleofsglt2iinattenuatingresidualcardiovascularriskthroughbloodpressureloweringmechanisticinsightsandperspectives AT nadruzwilson roleofsglt2iinattenuatingresidualcardiovascularriskthroughbloodpressureloweringmechanisticinsightsandperspectives AT quinagliathiago roleofsglt2iinattenuatingresidualcardiovascularriskthroughbloodpressureloweringmechanisticinsightsandperspectives AT spositoandreic roleofsglt2iinattenuatingresidualcardiovascularriskthroughbloodpressureloweringmechanisticinsightsandperspectives |